The European Medicines Agency’s (EMA) Committee for Medicinal Use Products (CHMP) recently recommended approval of six new biosimilars.

A research centre specialising in the financial reforms introduced by Manmohan Singh would be established at Bangalore ...

Biocon Ltd is quoting at Rs 352.1, up 1.63% on the day as on 12:49 IST on the NSE. The stock is up 42.35% in last one year as compared to a 9.51% jump in NIFTY and a 36.31% jump in the Nifty Pharma ...

Biocon’s stock jumped on December 24 after the United States Food and Drug Administration (USFDA) and the European Union ...

At the CXO-Entrepreneurs Alumni Meet 2024, hosted by MIT World Peace University (MIT-WPU), thought leaders and ...

Bengaluru: Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from ...

Shares of the biopharma major rose earlier today when it announced that its European partner, Zentiva, received a procedure ...

Biocon shares had gained earlier in the day after the company and its European partner Zentiva received a decentralised ...

Biocon and Zentiva Gain EU Approval for Generic Liraglutide - Biocon Limited , in collaboration with its European partner ...

The rise in Biocon share price came after it announced that the company and its European partner, Zentiva, have received a ...

The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight management.

Bangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex ...